Mark D. Pegram

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2”.

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

New England Journal of Medicine(2001)10.1056/nejm200103153441101

N/A

1.4DataRank · unranked

11469 citations

Brian Leyland-Jones, Steven Shak, Hank Fuchs, Virginia Paton, Alex Bajamonde +11 more

Mitochondrial copper depletion suppresses triple-negative breast cancer in mice

Nature Biotechnology(2020)10.1038/s41587-020-0707-9

N/A

0.878DataRank · unranked

347 citations

Arvin M. Gouw, Edward L. LaGory, Shenghao Guo, Nabeel Attarwala, Yao Tang +21 more

Immune cell repertoires in breast cancer patients after adjuvant chemotherapy

JCI Insight(2020)10.1172/jci.insight.134569

N/A

0DataRank · unranked

51 citations

Rohit R. Jadhav, Wenqiang Cao, Qian Qi, Mark D. Pegram, Lü Tian +3 more

Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer

PLoS ONE(2021)10.1371/journal.pone.0254783

N/A

0DataRank · unranked

7 citations

Wenchuan Liang, Chi‐Chih Kang, Mark D. Pegram, Amy E. Herr, John J. Kim